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ABSTRACT
The VP16 protein of herpes simplex virus is a potent
transcriptional activator of the viral immediate early
genes. The transcriptional activation region of VP16
can be divided into two functional subregions, here
designated VP16N (comprising amino acids 413–456)
and VP16C (amino acids 450–490). Assays of VP16C
mutants resulting from both random and alaninescanning mutagenesis indicated that the sidechains of
three phenylalanines (at positions 473, 475 and 479)
and one acidic residue (glutamate 476) are important
for transcriptional activation. Aromatic and bulky
hydrophobic amino acids were effective substitutes for
each of the three Phe residues, whereas replacement
with smaller or polar amino acids resulted in loss of
transcriptional function. In contrast, many changes
were tolerated for Glu476, including bulky hydrophobic
and basic amino acids, indicating that the negative
charge at this position contributes little to the function
of this subregion. Similar relative activities for most of
the mutants were observed in yeast and in mammalian
cells, indicating that the structural requirements for
this activation region are comparable in these two
species. These results reinforce the hypothesis that
bulky hydrophobic residues, not acidic residues, are
most critical for the activity of this ‘acidic’ transcriptional
activation region.
INTRODUCTION
Basal levels of transcription of eukaryotic mRNA genes by RNA
polymerase II can be augmented by the action of proteins known
as transcriptional activators. Several models have been proposed
for the function of eukaryotic activators, including the recruitment
of chromatin remodeling enzymes (1) or of basal transcription
factors. These latter interactions might facilitate pre-initiation
complex formation (2), increase initiation rate or aid in promoter
clearance (3) or increase the rate of elongation (4). Each of these
models invokes specific interactions between transcriptional

activation regions and particular target proteins that are likely to
require certain structural motifs present in the activator protein.
Therefore, transcriptional activators have been studied intensively to
identify such activation motifs.
Eukaryotic transcriptional activators were initially described
by the amino acids most abundantly present, resulting in classes
of acidic, glutamine-rich, proline-rich and serine/threonine-rich
regions (3,5), although some activation regions do not fit this
scheme (6). Thorough mutational analyses of acidic activation
regions from VP16 (7,8), RelA (9), p53 (10), Bel1 (11), Gcn4
(12), the glucocorticoid receptor (13,14), C1 (15) and of a
glutamine rich activation region from Sp1 (16), indicated that the
most prevalent types of amino acid were not those most critical
for activation function. Rather, in each case, specific bulky
hydrophobic or aromatic amino acids were more important.
This conclusion from mutational analyses is consistent with
results from biophysical experiments. Although activation regions in
isolation typically appear highly unstructured (17–21), more
ordered structures can be induced by the presence of putative
target proteins. Among the examples reported to date are the
interaction of the VP16 activation region with TBP (22) and with
hTAFII32 (23), the interaction of the p53 transcriptional activation
region with its repressor MDM2 (24), and the interaction of an
activation region from CREB with a fragment of CBP (25). In
each case, the interaction surface of the activator comprised
primarily hydrophobic residues (including many defined by
mutational analysis) within helical segments, with a notable lack
of participation by acidic sidechains.
VP16 (also known as Vmw65 or α-TIF) is a component of the
virion of herpes simplex virus whose transcriptional role is to
activate expression of the viral immediate early genes (reviewed
in 26). The 490 amino acids of VP16 can be divided into two
domains by biochemical or molecular genetic methods (27,28).
A region comprising the N-terminal 410 amino acids forms a
complex with the host proteins Oct-1 and HCF that can bind to
specific DNA sequences in the promoters of the immediate early
genes (26). The C-terminal 80 amino acids of VP16 are both
necessary and sufficient for transcriptional activation, even when
fused to a heterologous DNA-binding region (27,29,30). The
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MATERIALS AND METHODS
Plasmids and phage
The substrate for all mutagenesis reactions was mpPJH18, an
M13mp19 phagemid containing a SmaI–BamHI fragment encoding
VP16 residues 452–490 with 119 bp of 3′ untranslated sequence.
Mutants generated by error-prone PCR were screened in yeast
using pPJH13, a high copy (2µ LEU2) plasmid that expresses a
Gal4(1-147)–VP16C fusion protein from the ADH1 promoter.
Quantitative assays of transcriptional activation in yeast were
performed using wild type or mutant versions of pVS1, a low
copy plasmid (CEN6 ARSH4 LEU2) that expresses the
Gal4(1-147)–VP16C fusion protein, and the yeast reporter
construct pLGSD5 (35) containing the Escherichia coli lacZ

structural gene with the GAL1-10 upstream activating sequence
near the CYC1 promoter. VP16C mutants were also assayed in
mammalian cells using pSM71-1.VP16C, a derivative of pSGVP
(29) that expresses the Gal4(1-147)–VP16C fusion protein from
the SV40 early-gene promoter. The mammalian reporter plasmid
pG5BCAT (36) expresses the bacterial chloramphenicol acetyltransferase protein under the control of five Gal4 sites upstream
of the TATA sequence from the adenovirus E1B promoter.
Error-prone PCR-mediated mutagenesis
To generate random nucleotide substitutions, the VP16C coding
region of mpPJH18 was amplified by PCR using forward and
reverse M13 sequencing primers under reaction conditions that
diminish the accuracy of Taq DNA polymerase, including the
presence of MnCl2 (37) and limiting concentrations of dATP
(38). Reaction mixtures included 10 mM Tris–Cl (pH 8.8),
50 mM KCl, 0.5 mM MgCl2, 0.5 mM MnCl2, 0.4 mM dATP,
3.2 mM each dCTP, dGTP, dTTP, 100 µg/ml gelatin, 10 ng of
mpPJH18, 60 pmol of each primer, and 5 U of Taq DNA
polymerase (Perkin-Elmer) in a final volume of 100 µl. After an
initial melting step of 2 min at 94C, the temperature was lowered
to 80C and PCR was initiated by the addition of nucleotides and
polymerase. Amplification proceeded through 25 cycles (30 s
annealing at 43C, 2 min elongation at 72C, 30 s denaturation
at 94C). The PCR products were digested with SalI and BamHI,
ligated into pPJH13 and transformed into yeast strain BP1 (MATa
ura3-52 leu2-3, 2-112 Gal4::HIS4 ade1-100; 39).
Alanine scanning and site-directed mutagenesis
Oligonucleotide-directed mutations were generated in mpPJH18
using the method described by Kunkel (40). In some cases, a
variety of substitutions at specific positions were generated using
degenerate oligonucleotides. SalI–BglII fragments containing the
mutations were subcloned into pVS1 and resequenced to verify
the identities of mutations.
Yeast transformation and β-galactosidase assay
Plasmids expressing VP16C mutants fused to the Gal4 DNAbinding region were co-transformed with the reporter plasmid
pLGSD5 into yeast strains BP1 or PSY316 (MATa ade2-101
his3-del.200 leu2-3,2-112 lys2 ura3-53; 39) using the procedure
of Gietz et al. (41). To assay the activity of β-galactosidase
produced from pLGSD5, 2 ml cultures containing pools of ∼100
yeast transformant colonies were grown to early stationary phase
(OD600 = 0.9–1.2) in selective media, then diluted to OD600 = 0.1,
grown to mid-log phase (OD600 = 0.5) and harvested by
centrifugation. β-galactosidase activity was measured (42) using
extracts obtained from 5 ml cultures with results normalized to
protein concentration as determined by Bradford assay (43).
Yeast immunoblot analysis
To assess the steady-state levels of each mutant activator protein,
25 ml yeast cultures grown as described above were harvested by
centrifugation, washed once in water and resuspended in water to
a total volume of 100 µl. An equal volume of 4 SDS–PAGE
loading buffer lacking bromphenol blue was added and extracts
were boiled for 15 min, then centrifuged for 5 min at 14 000 g to
clarify the extract. Relative protein concentrations for each
extract were determined using a detergent compatible protein
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VP16 activation region can be further divided into two subregions
herein termed VP16N (amino acids 412–450) and VP16C (amino
acids 450–490), each of which is independently capable of
activation when provided with a DNA binding mechanism
(8,27,31–33).
Extensive mutational analysis of the VP16N subregion indicated
a key role for the aromatic character of F442 and supporting roles
for other bulky hydrophobic residues, specifically L439 and L444
(7,8). The acidic residues in this region had a much less important
role. Any one or even several negative charges could be removed
without significant loss of function. We and others have
previously tested the roles of several amino acids within the
C-terminal subregion of VP16. In one case, several substitutions
of F473 and F475 were tested in the context of full-length VP16
bearing the debilitating F442A mutation in the N subregion, with
the result that mutations at F475 had a somewhat greater effect
than corresponding mutations at F473 (8). In another study, the
simultaneous mutation of three phenylalanine residues within the
C subregion (i.e. F473, F475 and F479) to alanine had a dramatic
effect on the ability of that subregion to function in the context of
the full-length activation region (32).
These preliminary analyses, however, are insufficient to ensure
that all key amino acids in VP16C have been identified, and fall
short of defining the chemical characteristics of those amino acid
sidechains that contribute to the transcriptional activity of this
region. To comprehensively identify the critical residues in
VP16C and to further test the hypothesis that specific patterns of
hydrophobic residues are important for function of activation
regions, we have undertaken a thorough mutational analysis of
VP16C using both PCR-mediated random mutagenesis and
systematic alanine-scanning mutagenesis. Random mutagenesis
permits the analysis of a broad range of amino acid substitutions
altering the size, charge and hydrophobicity of the amino acid
sidechains. Moreover, the approach as applied here has the
advantage of an in vivo screening step which allows selection of
mutants defective in transcriptional activation. The complementary
strategy of alanine-scanning mutagenesis ensures that each amino
acid position will be tested and indicates the contributions of the
sidechain atoms of a given residue, because alanine substitutions
eliminate all sidechain atoms beyond the β-carbon (34). The
combination of these complementary mutational analyses, therefore,
provides information about each position while focusing on those
that affect activation most strongly. Our results indicate that in the
case of VP16C, as with other activation regions, specific hydrophobic amino acids are particularly critical to its transcriptional
function.
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assay (Bio-Rad), and ∼10 µg total protein were loaded per sample
onto 15% SDS–PAGE gels. Following electrophoresis, proteins
were electrophoretically transferred to nitrocellulose. Membranes
were blocked in 10% powdered milk, 20 mM Tris–Cl pH 7.5,
137 mM NaCl, 4 mM KCl, 0.01% Tween 20 and then incubated
sequentially with rabbit polyclonal antibodies raised against the
Gal4–VP16 fusion protein (LA2-3; L.Alexander and S.J.Triezenberg, unpublished) followed by goat anti-rabbit IgG conjugated
to horseradish peroxidase (Bio-Rad). Blots were developed using
an enhanced chemiluminescence system (ECL, Amersham or
Renaissance, DuPont NEN Life Science Products).
Mammalian plasmid construction and assay
The VP16C mutant activation regions were subcloned from the
yeast plasmids into pSM71-1.VP16C. All subclones were
sequenced to verify their identities. 100 ng of each plasmid were
co-transfected into mouse L cells (American Type Culture
Collection) with 1 µg pG5BCAT using DEAE–dextran (44).
Plates were incubated at 37C, 10% CO2 for 36–48 h, after which
cells were harvested by scraping into phosphate-buffered saline
followed by centrifugation. Cell extracts were made by freeze–
thawing and CAT assays were performed by the mixed-phase
method (45,46). Final reaction volumes of 100 µl contained 30 µl
of cell extract, 200 mM Tris–HCl pH 7.8, 4 mM EDTA, 30 mM
acetyl-CoA and 0.4 µCi [3H]acetyl CoA. Reactions were overlaid
with 10 ml Econofluor2 (Packard Industries), incubated for 2 h,
and quantitated using an LKB Wallace 1209 Rackbeta liquid
scintillation counter. Counts were normalized to protein
concentration as determined by Bradford assay (43).
Mammalian western blot analysis
Separate plates of L cells were transformed with 5 µg of each
plasmid encoding wild type or mutant Gal4–VP16 fusion protein
in the manner described above. After 36–48 h, cells were washed
once in phosphate-buffered saline and harvested by scraping into
200 µl of 4 SDS–PAGE loading buffer lacking bromphenol

blue. Samples were boiled for 10 min and then spun for 5 min at
14 000 g to clarify the extracts. Relative protein concentrations
were determined by using the Bio-Rad detergent-compatible protein
assay and western blots were performed as described above.
RESULTS
Biological selection of transcriptionally defective mutants of
VP16C
Expression of the wild type Gal4–VP16C fusion protein from a
high-copy plasmid is relatively toxic to yeast, as is the fusion
protein bearing the full-length VP16 activation region (39). As a
result, yeast strains expressing high levels of these activators
produce very small colonies. Mutations in the VP16 activation
region that reduce transcriptional activation also reduce the
toxicity (39), yielding larger yeast colonies. This phenomenon
was employed to screen a library of VP16C clones to identify
mutations that negatively affect transcriptional activity. A DNA
fragment encoding the VP16C subregion was amplified using Taq
DNA polymerase under error-prone conditions. The population of
amplified fragments was then ligated into a yeast expression
vector such that the VP16 coding sequences were in frame with
sequences encoding the Gal4 DNA-binding domain. This library
was then transformed into yeast cells and large colonies were
selected. DNA fragments encoding the VP16C subregion were
isolated from these colonies and were sequenced. These fragments
were then cloned into a low-copy yeast plasmid from which
expression of the Gal4–VP16C fusion protein is sufficiently low
to avoid the toxicity. Transcriptional activation by the mutant
fusion proteins was quantitatively assessed using a β-galactosidase
reporter gene with a Gal4-responsive promoter (Fig. 1).
Of the 14 PCR-generated mutants in VP16C isolated by this
approach, 11 have at least one amino acid substitution between
positions 470 and 480. Eight of the 13 missense mutants have
changes at one or more of the phenylalanines in this region (F473,
F475 and F479). Moreover, all mutants displaying ≤40% of wild
type activity bear a substitution at one or more of these
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Figure 1. Mutation identities and relative activities of VP16C mutants selected for reduced toxicity when highly expressed in yeast. The Gal4–VP16C fusion protein,
when expressed from the ADH1 promoter on a high-copy plasmid, is toxic to yeast resulting in tiny colonies. The VP16C mutants listed here, generated by error-prone
PCR, were selected based on larger yeast colony size. The VP16C subregions were then recloned into a low-copy vector (to avoid toxicity) and assayed for
transcriptional activity using a Gal4-reponsive lacZ reporter plasmid (pLGSD5). Below the amino acid sequence of VP16C (residues 450–490) are shown the positions
and types of substitutions identified in each of these mutants. The β-galactosidase activities in lysates of cells containing each of the Gal4-VP16C mutants are expressed
relative to the activity of the wild type Gal4–VP16C fusion protein.
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Alanine scanning mutagenesis of VP16C
As a complement to the random mutagenesis and to more
systematically assess the importance of each residue of VP16C
individually, we constructed alanine substitutions at each position
(except those that were originally alanine or glycine). The 27
mutants created in this set were tested as Gal4–VP16C fusion
proteins, expressed from a low-copy plasmid, for the ability to
activate a Gal4-responsive β-galactosidase reporter gene in yeast.
The results (Fig. 2) support the conclusion derived from the
PCR-generated mutants that the most critical residues for
activation byVP16C lie between positions 470 and 480. Only four
of the 27 alanine mutants have activity <70% of that of wild type.
Three of these mutations affect phenylalanines: F473A (51%
activity), F475A (21% activity) and F479A (43% activity). A
double mutant with alanine substitutions at both positions 473 and
475 showed ≤1% activity. The fourth mutant with a significant
loss of activity was E476A, which displayed only 38% of wild
type activity. This result suggests that the sidechain of E476
contributes to the function of VP16C, despite the fact that this site
was not affected in any of the randomly-generated mutants
isolated in the previous experiment. All other alanine substitutions
had little or no effect on transcriptional activation in yeast assays.
To determine whether activation by VP16C in mammalian cells
depends on the same amino acids as in yeast, the alanine
substitution mutants were also assayed as Gal4 fusion proteins in
mouse L cells. Plasmids expressing the Gal4–VP16C proteins
from the SV40 early promoter were cotransfected with pG5Bcat,
a reporter plasmid in which expression of chloramphenicol
acetyltransferase (CAT) is controlled by Gal4-binding sites (36).
After 36–48 h, the CAT enzyme activity in cell extracts was
assayed as an indication of the ability of the Gal4–VP16C protein
to activate transcription. The results shown in Figure 3 are very
similar to the results of assaying the mutants in yeast. As in yeast,
the mutants with the most significant effects (i.e. activity ≤60%)
have substitutions of the phenylalanine residues at positions 473
(49%), 475 (25%) or 479 (22%), or the glutamate residue at 476
(60%). Two other mutants, T458A and H460A, have activities

<70% (67 and 62%, respectively) in mammalian cells, although
their activities in yeast assays were close to wild type levels. All
other alanine substitutions had little or no effect on transcriptional
activity in mammalian cells.
Side-chain preferences at key positions in VP16C
The random and systematic mutational analyses described in the
preceding sections indicate that F473, F475, E476 and F479 are
the residues most critical for the transcriptional function of
VP16C in both yeast and mammalian systems. The strong activity
of the mutants bearing phenylalanine to leucine substitutions,
derived from the PCR-mediated mutagenesis, suggested that the
hydrophobic character of the amino acids at those positions is
more important than is the aromatic character, in contrast to
previous observations for the F442 residue in VP16N. Therefore,
to more clearly determine the chemical characteristics most
important for the sidechains of the amino acids at these positions,
we constructed a number of substitutions at each site and tested
the ability of these mutants to activate transcription in yeast and
in mammalian cells.
Each of the three key phenylalanine residues was altered to
other aromatic amino acids, non-aromatic bulky hydrophobic
amino acids, small hydrophobic amino acids, small hydrophilic
residues and charged or polar residues. When assayed in yeast, the
effects of a particular type of substitution were quite similar at
each of the three Phe positions tested (Fig. 4A, B and E).
Substitutions of phenylalanine with either aromatic or bulky
hydrophobic residues resulted in proteins with at least 50% of
wild type activation ability. Even a double mutation to leucine at
positions 473 and 475 retained ∼60% of wild type activity (Fig. 4B).
Alterations at these positions to residues with smaller or
hydrophilic sidechains, however, reduced activity to ≤50%.
These data support the hypothesis that hydrophobic character is
the most significant criterion of these residues that are critical for
activation. Interestingly, effects at positions 475 and 479 were
more severe than those at 473. Changes resulting in sidechains
that are not bulky and hydrophobic only reduced activity to
between 50 and 30% for 473, whereas for 475 and 479, activity
was <25% for all of these changes. This result may indicate that
F473 is less important for transcriptional activation than are F475
and F479.
When assayed in mammalian cells, the substitutions at
positions 475 and 479 produced results similar to those obtained
in yeast. At these positions, the activities of mutants with
hydrophobic amino acid substitutions were at least 60% of wild
type respectively, while substitutions with non-hydrophobic
residues yielded activities <30% of that of the wild type protein
(Fig. 5B and E). Again, these results support the hypothesis that
the hydrophobic nature of residues at these positions is important for
activation by VP16C. A double mutant with leucines at positions
473 and 475 also retained >30% wild type activity (Fig. 5B).
The indication that F473 is less important than F475 or F479
is demonstrated even more clearly in the mammalian system than
in yeast. In the mammalian assays, the only F473 mutant with
activity below 75% bore a substitution to alanine (Fig. 5). Thus,
whereas F473 is less important in yeast than are the other
phenylalanine residues, it contributes very little to the activity of
VP16C in the mammalian cell assay.
The only substitution of an acidic residue with alanine that had
a significant effect was E476A (Figs 2 and 3). To test the chemical
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phenylalanine residues, with the exception of the L468P/M478V
mutant. For two of these three phenylalanines, substitution to
leucine resulted in only a relatively modest defect: in β-galactosidase
assays, F475L and F479L displayed 78 and 90% of wild type
activity, respectively. Substitutions at these positions to a
hydrophilic residue such as serine, however, resulted in large
defects. The mutant F473S retained only 26% of wild type
activity, and the two mutants with serine substitutions at F479
(F479S/D486G and F475S/M478T/F479S), showed ≤10% of
wild type levels. These results indicate the important role of bulky
hydrophobic or aromatic groups at positions 473, 475 and 479 for
transcriptional activation by VP16C.
Interestingly, the fourth phenylalanine residue in VP16C, F457,
seems much less important. This position was altered in only two
of the mutants isolated by this approach. The F457L/F479L
mutant activated the reporter gene at nearly wild type levels. The
F457S mutant showed 63% of wild type activity, a modest
reduction compared to serine substitutions at the other phenylalanine
positions. This result supports the idea that residues between 470
and 480, not simply any bulky hydrophobic or aromatic residues
in the vicinity, were primarily responsible for the transcriptional
activity of VP16C.
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characteristics that might be important at that position, mutants
were constructed in which the glutamate was replaced with other
acidic, uncharged, nonpolar or even basic amino acids (Figs 4C
and 5C). The E476D and E476Q mutants functioned with
essentially wild type activity in both yeast and mammalian cells,
indicating that the charge and length of the sidechain are not
critical parameters. Moreover, a mutant with reversed charge
(E476K) and mutants with aliphatic rather than polar sidechains
(E476M, E476L and E476P) were also at least 50% active in yeast
and (with the exception of E476L) also in mammalian cells. The
wide range of substitutions that do not significantly affect activity in
either assay system suggests that the nature of the side chain at
position 476 is not particularly critical for activation by VP16C.
Mutations at position 478 seem to affect the function of VP16C
differently in the yeast and mammalian systems. In the yeast
assays, leucine was an effective substitute for methionine at this
position, retaining 85% activity, while alanine and serine
diminished activity to 50 and 40% of wild type levels, respectively
(Fig. 4D). In the mammalian assays, however, none of these
changes significantly affected activation ability (Fig. 5D). This
observation suggests at least some difference in the structures
required for activation in the yeast and mammalian systems.
The steady-state levels of all Gal4–VP16C proteins studied in
this work were assessed by immunoblot analysis. Expression of

Gal4–VP16 mutants in yeast cells was assayed using aliquots of
the whole-cell extracts used for β-galactosidase assays. Expression of mutant fusion proteins in mammalian cells was tested by
transfecting mouse L cells with 5 µg of each expression plasmid
and collecting whole cell extracts 2 days after transfection.
Samples containing equivalent amounts of total protein were
electrophoresed in SDS–polyacrylamide gels, blotted to nitrocellulose and probed with a polyclonal antiserum raised against
recombinant Gal4–VP16 fusion protein. The results of typical
immunoblots are shown in Figure 6, which explicitly demonstrates that the mutant proteins with the greatest defects in
transcriptional activity are nonetheless present at levels similar to
or greater than the wildtype fusion protein. Similar results were
obtained for each of the proteins whose transcriptional activities
are represented in Figures 2–5 (data not shown). Therefore, the
differences in transcriptional activity cannot be attributed to
differences in expression or stability of the mutant activator
proteins.
DISCUSSION
The first evidence that bulky hydrophobic amino acids, rather
than the abundant acidic amino acids, were most critical for the
function of an acidic transcriptional activation region was observed
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Figure 2. Relative activities in yeast of alanine-scanning mutants of the VP16C subregion. Alanine substitutions were constructed at each position of VP16C except
glycines and existing alanines. The activities of Gal4–VP16C fusion proteins bearing these substitutions were assayed using a β-galactosidase reporter gene as
described in the legend to Figure 1. The position of each mutation is represented by the amino acid sequence of VP16C along the horizontal axis of this figure. Bars
indicate mean activity (with standard deviation) of β-galactosidase in yeast cell extracts from at least three parallel cultures, expressed relative to the activity of the
wild type Gal4–VP16C fusion protein (indicated by +). β-galactosidase activities in extracts lacking the Gal4–VP16C fusion protein (indicated by –) were negligible.
A double substitution of alanine for both F473 and F475 is shown at the right end of the figure.
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in studies of the N-subregion of the VP16 transcriptional activation
region (VP16N, amino acids 411–456; 7,8). In the present study,
we employed two complementary mutational strategies, unbiased
with respect to this hypothesis, to identify key amino acids in the
VP16 C-subregion (VP16C, amino acids 450–490). The results
of both alanine scanning and PCR-mediated random mutagenesis
indicated that three phenylalanine residues, at positions 473, 475
and 479, contribute significantly to activation, with F475 being
the most critical. Other aromatic or bulky hydrophobic amino acid
sidechains apparently contribute relatively little to transcriptional
activation by VP16C, because most substitutions replacing
Phe457, Tyr465, Leu468, Met470, Ile485 and Tyr488 had little
effect on transcriptional activity. We cannot exclude the possibility
that amino acid substitutions with more drastic changes in
sidechain characteristics might affect transcriptional activity, as
suggested by the 60% loss of activity in yeast when Leu468 was
replaced by proline (Fig. 1) or when Met478 was altered to serine
(Fig. 4D).
Thus, as previously observed for VP16N (7,8), aromatic
residues are particularly important for the function of the
C-subregion. However, the changes in chemical characteristics of
those amino acid sidechains that can be tolerated with little loss
of activity differ between the two subregions of VP16. The
critical phenylalanine residue of VP16N, F442, could only be

functionally replaced by other aromatic residues (8). In contrast,
any of the bulky hydrophobic amino acids leucine, isoleucine and
valine, as well as cysteine and the aromatic residues tyrosine and
tryptophan, could effectively substitute for the key phenylalanines in
VP16C (Figs 4 and 5).
Although most of the acidic residues of VP16C could be altered
(at least to alanine) without affecting transcriptional activation,
our results indicate contributions by the glutamate residues at
position 476 and possibly at position 474, two sites flanking the
most critical phenylalanine. The alanine scanning results shown
in Figures 2 and 3 demonstrate that the single replacement of
E476 with alanine reduced the activity of VP16C by half in both
yeast and mammalian cells. The negative charge of the amino
acid sidechain at this position seems dispensable, however, since
mutants bearing non-polar, polar and even basic amino acids at
that position retained significant activity (Figs 4C and 5C). No
other replacement of an acidic residue with alanine showed any
significant effect in our experiments. However, the replacement
of E474 with glycine had modest but reproducible effects in the
context of the E474G/F475L and F473S/E474G double mutants
when compared with the F475L and F473S single mutants (Fig. 1).
The transcriptional effect of glycine but not alanine at this
position might be due to the destabilizing effects of glycine
substitutions on protein secondary structures.
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Figure 3. Relative activities of Gal4–VP16C alanine-scanning mutants in mammalian cells. Each of the alanine-scanning mutations described in Figure 2 was recloned
into a mammalian expression plasmid and transfected into mouse L cells with a reporter gene that expresses chloramphenicol acetyltransferase under control of Gal4
binding sites (pG5BCAT). The CAT enzyme activities in cell extracts were assayed by the fluor-diffusion method, adjusted to ensure that measurements were within
the linear range of the assay. Bars indicate mean activities (with standard deviations) of CAT activity from at least three plates of cells transfected with a given
Gal4–VP16C mutant expression plasmid, relative to the activity of the wild type Gal4–VP16C plasmid (indicated by +).
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The relative unimportance of individual acidic amino acids in
VP16C is consistent with prior observations of VP16N and
several other eukaryotic transcriptional activation regions
(7,8,10–15,47,48) in which the negatively charged sidechains
seem relatively unimportant for transcriptional activation. For
example, when four aspartate residues surrounding the critical
Phe442 in VP16N were substituted by asparagine (removing the
negative charge) or by glutamate (retaining the charge on a longer
sidechain), the asparagine substitutions had less effect (7).
Moreover, when single alanine substitutions were tested in
VP16N at positions D440, D441, D443 and D445, only the
D443A mutation had a significant effect (J.Kastenmayer,
P.J.Horn and S.J.Triezenberg, unpublished). Thus, in both VP16C
and VP16N the only acidic residue whose replacement by alanine
has a significant effect is the residue immediately following the
most critical phenylalanine.
In most cases, substitutions in VP16C had roughly equivalent
effects when tested in yeast and in mammalian cells. This result

implies that similar structural features are required for this
activation region to function in cells of these two disparate
species, and might be construed to suggest that mechanisms of
transcriptional activation are also conserved. An alternative
hypothesis is that the specific targets of the activating region
differ in yeast and in humans, but that similar structural features
of the activator are nonetheless integral to each of those distinct
interactions. Careful analysis of protein–protein interactions and
the transcriptional consequences of those interactions is necessary
to discriminate between these two hypotheses.
Eukaryotic transcriptional activation regions bind in vitro to a
number of putative target proteins. VP16, for example, has been
shown to bind directly to TFIIA (49), TBP (50), dTAFII40 or
hTAFII32 (33,51), TFIIB (52), TFIIH (53) and the yeast adaptor
ADA2 (54). Questions remain as to which if any of these
interactions are relevant to transcriptional activation in vivo, and
whether the same hydrophobic interface is employed in each
interaction. This question can be addressed in part by detailed
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Figure 4. Relative activities in yeast of Gal4–VP16C mutants bearing various amino acid substitutions at specific positions. Mutant Gal4–VP16C proteins with
substitutions at F473 (A), F475 (B), E476 (C), M478 (D) or F479 (E), were assayed for their ability to activate expression of a β-galactosidase reporter gene as described
in Figure 1. The individual substitutions are indicated along the horizontal axis of each panel in descending order of activity from left to right, with the mean activity
(with standard deviations) from at least three cultures for each mutant being represented by a vertical bar. (B) also indicates the activity of one mutant with leucine
substitutions at both F473 and F475.
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biochemical experiments assessing the roles of activators at
particular steps in the transcriptional activation process. For
example, the VP16C activation region (and others) can bind to
TFIIA and can enhance the rate of formation and the stability of
a complex comprising TFIIA, TFIID and promoter DNA (49).
When a subset of the VP16C mutants described in this report was
tested for this property, a significant correlation was observed
between the level of transcriptional activation and the ability to
bind TFIIA and to stimulate formation of TFIIA/TFIID/DNA
complexes (55). This result is consistent with models invoking
recruitment of TFIID as an early step in the mechanism of
transcriptional activation (2,56).
Given the propensity of hydrophobic amino acid sidechains to
be buried in protein tertiary structures, two simple models can be
proposed for the role of such residues in transcriptional activation
regions. On one hand, hydrophobic residues may be required for
activation because, by interactions with each other, they facilitate
formation of a structure that presents other amino acids for

interaction with target proteins in the transcriptional machinery.
The systematic analysis by alanine-scanning mutagenesis of the
VP16C subregion argues against this model, for we found little
evidence for the critical role of any other amino acids in
transcriptional activation. Alternatively, the critical hydrophobic
residues may remain exposed on the surface of the activation
region to directly participate in the interaction with other proteins.
These residues might then be buried in the interface created when
the activation region associates with its target.
The biophysical evidence presently available for VP16 cannot
clearly distinguish between these two hypotheses, although
results from studies of other activators favor the latter model.
Fluorescence spectrosopy of the VP16 activation region revealed
that key aromatic residues at positions 442 and 473 were constrained
into a less flexible and more hydrophobic environment in the
presence of TBP (22), but did not demonstrate that these residues
make direct contact with TBP. A recent NMR study revealed that
an α helix was induced in VP16C when hTAFII32 (a component

Downloaded from https://academic.oup.com/nar/article/26/19/4487/1056126 by Calvin College / Hekman Library user on 10 June 2022

Figure 5. Relative activities in mammalian cells of Gal4–VP16C fusion proteins with various substitutions at specific positions. Each of the VP16C mutants described
in Figure 4 was recloned into a mammalian expression vector and assayed for the ability to activate expression of a CAT reporter gene as described in Figure 2. The
individual substitutions are indicated along the horizontal axis of each panel in descending order of activity from left to right, with the mean activity (with standard
deviations) from at least three plates of transfected cells for each mutant being represented by a vertical bar.
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of TFIID) was present (23). Of the three amino acid sidechains
within this helix that showed significant changes in chemical shift
upon interaction with TAFII32, two (F479 and L483) are bulky
hydrophobic residues and the third (D472) is acidic. However, these
changes in chemical shift do not necessarily imply that those
sidechains directly participate in the interaction. Moreover, the
results of this NMR analysis are at odds with the mutational analysis
described in the present report, in which F473 and especially F475
are shown to play key roles in transcriptional activation whereas
alanine substitutions of D472 and L483 had no apparent effect.
Thus, one might have expected the NMR experiments to show
pronounced chemical shifts involving the sidechains of F473 and
F475. It may be that these residues are not involved in interactions
with hTAFII32, but are critical for some other interaction required for
transcriptional activation. Alternatively, the in vitro interaction of
VP16C with hTAFII32 may not represent an essential step in the
process of transcriptional activation. We are presently testing our
panel of VP16C mutations at these positions for their effects on
binding to hTAFII32 and other potential target proteins (P.J.Horn,
Y.Nedialkov and S.J.Triezenberg, unpublished results).
Two studies offer strong evidence that the hydrophobic
residues of some activating regions form surfaces that interact
directly with target proteins. In a crystallographic analysis of a
peptide representing the p53 transcriptional activation region
complexed with its repressor MDM2 (24), the p53 peptide folded
into a helix in which transcriptionally-important hydrophobic
residues formed the interacting surface. The NMR solution
structure of a complex containing a peptide from the activation
region of CREB and its interacting region from the coactivator
protein CBP also showed a transition of the activation region
from random coil to amphipathic helix (25). In this case, the
interaction surface involved hydrophobic residues of the activation

region and a hydrophobic groove of the coactivator, reinforced by
electrostatic and hydrogen-binding interactions contributed by
acidic and phosphoserine residues of the activator. We hypothesize
that a similar hydrophobic surface of VP16C, encompassing the
phenylalanine residues at 475 and 479, may interact with target
proteins at key steps along the pathway to transcriptional
activation, but the identification of those key steps, the relevant
target proteins at those steps, and the structure of VP16 when
interacting with those target proteins, await further study.
The mutational, biochemical and biophysical studies summarized
above lead to a model in which transcriptional activation by VP16
and other eukaryotic activators requires biochemical interactions
between activation regions and specific target proteins that
depend most directly upon hydrophobic residues within helical
segments of the activator, with relatively minor or non-specific
contributions made by acidic sidechains. The biophysical evidence
that in at least some circumstances these hydrophobic residues are
present in helical segments induced by the presence of the target
protein recalls to mind the amphipathic helix model introduced early
in the study of eukaryotic activators (57,58). This model originally
posited that activation regions would fold into amphipathic
α-helices, the acidic face of which would comprise the interaction
surface with targets such as the basic regions of TBP and TFIIB.
The present evidence, while largely consistent with the formation
of helices in activating regions, suggests instead that hydrophobic
surfaces are key to interactions with target proteins, whereas the
acidic residues may be present for bringing these otherwise buried
regions to the surface, for long-range electrostatic interactions
that might facilitate docking, or for minor supporting roles in the
induced interaction structure. A remaining question is whether
the same secondary structure and hydrophobic interaction surface
will suffice for interactions of a given activator, such as VP16,
with each of its various putative target proteins, and if so how this
promiscuous interaction surface can nonetheless retain sufficient
specificity to effectively accomplish its transcriptional task in the
complex environment of the eukaryotic nucleus.
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